Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinica
about
Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case ReportManagement Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.Hereditary pancreatic cancer: related syndromes and clinical perspective.Liquid biopsy for detection of actionable oncogenic mutations in human cancers and electric field induced release and measurement liquid biopsy (eLB)Genetics of pancreatic neuroendocrine tumors: implications for the clinic.Translational Diagnostics and Therapeutics in Pancreatic Neuroendocrine Tumors.Whole-genome landscape of pancreatic neuroendocrine tumours.
P2860
Q28078610-D0C10886-2D2F-4DB1-BAFC-B4BA454A8A29Q33570568-5D8ADC5E-AAB6-4F29-BA03-EB6D8AA1754FQ33737587-2FD91726-731E-4FDA-A794-4EE28A092C4AQ33851085-5DFE89C9-8D26-45CC-BDDC-29AD671D818DQ36430821-EF7EEEDF-14C8-4B56-A515-BB29E26FCE4BQ36960581-9E0B7331-D742-4951-B600-0961B5624470Q42379480-765A7652-CE62-4E44-935E-D50991B805D6Q51137102-AFFAA431-5918-4603-93EF-5DF04D2981AA
P2860
Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinica
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mutation-targeted therapy with ...... rotocol for a phase II clinica
@ast
Mutation-targeted therapy with ...... rotocol for a phase II clinica
@en
type
label
Mutation-targeted therapy with ...... rotocol for a phase II clinica
@ast
Mutation-targeted therapy with ...... rotocol for a phase II clinica
@en
prefLabel
Mutation-targeted therapy with ...... rotocol for a phase II clinica
@ast
Mutation-targeted therapy with ...... rotocol for a phase II clinica
@en
P2093
P2860
P1433
P1476
Mutation-targeted therapy with ...... rotocol for a phase II clinica
@en
P2093
Candice Cottle-Delisle
Electron Kebebew
Jianhua Yao
Naris Nilubol
Paul Meltzer
Roxanne Merkel
Seth M Steinberg
Stephen Marx
Vladimir Neychev
P2860
P304
P356
10.1136/BMJOPEN-2015-008248
P50
P577
2015-05-19T00:00:00Z